Site Logo

Contact Us

Pater Eeuwensweg 36
Willemstad Curaçao

Email Us

info@cbhri.com
www.cbhri.com

Phone

+5999 788 9903
(Mon-Fri)

Publications

Response to: Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM-2): results from a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Haematol, in press.

Authors: Van Dijck R, Schnog JB, Te Boekhorst PAW.

2024

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit.

BJC Rep
2024, Volume 2(1):45.
Authors: Schnog JB, Duits AJ, Samson MJ.

2024

Pharmaceutical company funding of cancer patient advocacy organizations in the Netherlands.

J Cancer Policy
2024, Volume 41: 100493.
Authors: Somers AMJ, Duits AJ, Samson MJ, Schnog JB.

2024

Pharmaceutical Industry Payments to Medical Oncologists in the Netherlands: Trends and Patterns Provided by an Open-Access Transparency Data Set.

JCO Oncology Practice
2024, Volume 20: 843-851.
Authors: Schnog JB,  Izzy Gerstenbluth, Duits AJ.

2024

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies.

Lancet Reg Health Am.
2023, Volume 25: 100584.
Authors: de Vocht DECM, Schnog JB,  Merkies IS, Samson MJ.

2023

An analytical view of the BJH publication of ‘a clinician’s view of voxelotor’.

Br J Haematol
2023, Volume 200(6):e56-e57.
Authors: Schnog JB,  Samson MJ, Duits AJ.

2023

Financiële belangen en oncologische geneesmiddelen [Financial conflict of interest and anti-cancer drugs: Why the NTVG’s stance to exclude pharma-advertisement is of importance.]

Ned Tijdschr Geneeskd.
2022, Volume 166:D6738.
Authors: Schnog JB,  Samson MJ, Duits AJ.

2022

Trastuzumab Deruxtecan in HER2-Low Breast Cancer. 

N Engl J Med
2022, Volume 387:1143-1144.
Authors: Schnog JB,  Samson MJ, Duits AJ.

2022

Contemporary oncology trials, drug approvals and the physician-patient relationship. 

The Lancet Regional Health-Americas
2022, Volume 11:100247.
Authors: Schnog JB,  Samson MJ, Duits AJ.

2022

Long-term Chikungunya sequelae and quality of life 2.5 years post-acute disease in a prospective cohort in Curaçao

PLoS Negl Trop Dis.
2022, PLoS Negl Trop Dis 16(3): e0010142
Authors: Churnalisa Doran, Jelte Elsinga, Ante Fokkema, Kevin Berenschot, Izzy Gerstenbluth, Ashley Duits, Norediz Lourents, Yaskara Halabi, Johannes Burgerhof, Ajay Bailey, Adriana Tami.

2022

An urgent call to raise the bar in oncology.

Br J Cancer.
2021, Volume 125:1477-1485.
Authors: Schnog JB,  Samson MJ, Gans ROB, Duits AJ.

2021

Rapid Identification of Druggable Targets and the Power of the PHENotype SIMulator for Effective Drug Repurposing in COVID-19

Res Sq
2021, Apr 14:rs.3.rs-287183. doi: 10.21203/rs.3.rs-287183/v1. Preprint.PMID: 33880466
Authors: Maria N, Rapicavoli RV, Alaimo S, Bischof E, Stasuzzo A, Broek J, Pulvirenti A, Mishra B, Duits A, Ferro A. 

2021

Quality Improvement in a small‐scale Caribbean Blood Bank: the value of long‐term collaboration and stepwise process approach

ISBT Science Series
Volume 16, Issue 4 First published: 29 March 2021
Authors:  Ashley J. DuitsLuigi SilléWillem M. Smid

2021

Neurologic sequelae of severe chikungunya infection in the first 6 months of life: a prospective cohort study 24-months post-infection

BMC Infect Dis
2021, 21, 179 .
Authors: van Ewijk R, Huibers MHW, Manshande ME, Ecury-Goossen GM, Duits AJ, Calis JC, van Wassenaer-Leemhuis AG.

2021

Community participation in mosquito breeding site control: an interdisciplinary mixed methods study in Curaçao

Parasites & Vectors
2017, Volume 10:434
Authors: Jelte Elisinga, Henry T. van der Veen,  Izzy Gerstenbluth, Johannes G. M. Burgerhof, Arie Dijkstra, Martin P. Grobusch, Adriana Tami and Ajay Bailey.

2017

Health-related impact on quality of life and coping strategies for chikungunya: a study in Curaçao

PLOS Neglected Tropical Diseases
2017, Volume 11(10): e0005987

Authors: Jelte Elisinga, Martin P. Grobusch, Adriana Tami,  Izzy Gerstenbluth and Ajay Bailey.

2017

Hyperferritinemia is a potential marker of chronic chikungunya: a retrospective study on the Island of Curaçao during the 2014-2015 Outbreak

Journal of Clinical Virology
2017, Volume 18: 31-38
Authors: Fatih Anfasa, Lisette Provacia, Corine Geurts van Kessel, Robert Wever, Izzy Gerstenbluth, Albert D. M. E. Osterhaus and Byron E. E. Martina.

 

2017

The pathogenesis of chronic chikungunya: evolving concepts

Future Virology
2016, Issue: 11.1: 61-77
Authors: Roosenhoff, Rueshandra, Fatih Anfasa, and Byron Martina.

2016